BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 16124168)

  • 41. Case-control studies of screening procedures.
    Knox G
    Public Health; 1991 Jan; 105(1):55-61. PubMed ID: 2008504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Invasive cervical cancer in members of a prepaid health plan: the effect of menopausal status on disease characteristics.
    Sawaya G; Sung H; Kearney K; Miller M; Kinney W; Hiatt R
    J Low Genit Tract Dis; 1999 Jan; 3(1):41. PubMed ID: 25950313
    [No Abstract]   [Full Text] [Related]  

  • 43. Equal Management of Equal Risks: What Should be Used as the Standard for Cervical Cancer Prevention?
    Kinney WK; Perkins RB; Sawaya GF
    J Low Genit Tract Dis; 2018 Jul; 22(3):237-241. PubMed ID: 29794532
    [No Abstract]   [Full Text] [Related]  

  • 44. A population-based evaluation of cervical screening in the United States: 2008-2011.
    Cuzick J; Myers O; Hunt WC; Robertson M; Joste NE; Castle PE; Benard VB; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):765-73. PubMed ID: 24302677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advancing age and cervical cancer screening and prognosis.
    Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
    J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health plan.
    Sawaya GF; Sung HY; Kinney W; Kearney KA; Miller MG; Hiatt RA
    Acta Cytol; 2005; 49(4):391-7. PubMed ID: 16124168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical cancer screening. Past success and future challenge.
    Dewar MA; Hall K; Perchalski J
    Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.